| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Michael J Edel | Q63364026 |
| P2093 | author name string | Kevin O'Connor | |
| Michaela Lucas | |||
| Meilyn Hew | |||
| P2860 | cites work | Environmental risk factors for multiple sclerosis. Part I: The role of infection | Q22252937 |
| Generation of β cells from human pluripotent stem cells: are we there yet? | Q26823732 | ||
| Regulatory dendritic cells for immunotherapy in immunologic diseases | Q26866216 | ||
| A functional and structural basis for TCR cross-reactivity in multiple sclerosis | Q27639679 | ||
| Targeting dendritic cell function during systemic autoimmunity to restore tolerance | Q27687098 | ||
| Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
| Reprogramming of human somatic cells to pluripotency with defined factors | Q28262710 | ||
| Clinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosis | Q28275482 | ||
| Multiple sclerosis | Q28299151 | ||
| Regulatory dendritic cells: there is more than just immune activation | Q28388235 | ||
| GWAS identifies novel SLE susceptibility genes and explains the association of the HLA region | Q28943388 | ||
| Immunobiology of dendritic cells | Q29547465 | ||
| In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state | Q29614212 | ||
| Risk alleles for multiple sclerosis identified by a genomewide study | Q29614890 | ||
| Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo | Q29616178 | ||
| Suppression of glomerulonephritis in NZB/NZW lupus prone mice by adoptive transfer of ex vivo expanded regulatory T cells | Q33473900 | ||
| Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis. | Q34171788 | ||
| Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model | Q34230589 | ||
| Induced pluripotent stem cells: past, present, and future | Q34281955 | ||
| Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis | Q34311395 | ||
| Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells | Q34321823 | ||
| Generation of human induced pluripotent stem cells from dermal fibroblasts | Q34588555 | ||
| The functional and molecular characterisation of human embryonic stem cell-derived insulin-positive cells compared with adult pancreatic beta cells | Q50507992 | ||
| Leukemia inhibitory factor inhibits T helper 17 cell differentiation and confers treatment effects of neural progenitor cell therapy in autoimmune disease. | Q54568316 | ||
| Neuropotent self-renewing neural stem (NS) cells derived from mouse induced pluripotent stem (iPS) cells | Q56798181 | ||
| CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid | Q56903335 | ||
| Stable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients | Q61656600 | ||
| Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10 | Q78804319 | ||
| Immune modulation and tolerance induction by RelB-silenced dendritic cells through RNA interference | Q80178345 | ||
| Antigen-specific suppression of established arthritis in mice by dendritic cells deficient in NF-kappaB | Q80544759 | ||
| Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism | Q81629331 | ||
| The major histocompatibility complex and multiple sclerosis: a smoking gun? | Q83395346 | ||
| Differentiation of induced pluripotent stem cells into functional oligodendrocytes | Q83711646 | ||
| The immunogenetics of multiple sclerosis | Q34776567 | ||
| Clinical therapy using iPSCs: hopes and challenges | Q35171879 | ||
| RelB nuclear translocation regulates B cell MHC molecule, CD40 expression, and antigen-presenting cell function. | Q35292814 | ||
| Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells | Q35867877 | ||
| Programming of regulatory T cells from pluripotent stem cells and prevention of autoimmunity | Q36106606 | ||
| Derivation of human induced pluripotent stem cells from patients with maturity onset diabetes of the young | Q36635948 | ||
| Transgene-free disease-specific induced pluripotent stem cells from patients with type 1 and type 2 diabetes | Q36839889 | ||
| Multiple sclerosis: a complicated picture of autoimmunity. | Q36915907 | ||
| The Foxp3+ regulatory T cell: a jack of all trades, master of regulation | Q37088900 | ||
| Human regulatory T cells: role in autoimmune disease and therapeutic opportunities | Q37211296 | ||
| Oligodendrocyte differentiation and implantation: new insights for remyelinating cell therapy | Q37260245 | ||
| Generation of pluripotent stem cells from patients with type 1 diabetes | Q37327472 | ||
| Generation and characterization of regulatory dendritic cells derived from murine induced pluripotent stem cells | Q37555225 | ||
| Update on the genetic risk factors for rheumatoid arthritis | Q37729042 | ||
| Induced pluripotent stem cells: a new revolution for clinical neurology? | Q37857439 | ||
| Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis | Q37863350 | ||
| Neural stem cell transplantation in central nervous system disorders: from cell replacement to neuroprotection | Q38006628 | ||
| Immunopathogenic mechanisms of systemic autoimmune disease | Q38133018 | ||
| The potential of cell-based therapy for diabetes and diabetes-related vascular complications | Q38181982 | ||
| Multiple sclerosis and the role of immune cells. | Q38254152 | ||
| Role of dendritic cells in the initiation, progress and modulation of systemic autoimmune diseases | Q38275585 | ||
| Cellular therapies based on stem cells and their insulin-producing surrogates: a 2015 reality check | Q38344424 | ||
| Neural differentiation of patient specific iPS cells as a novel approach to study the pathophysiology of multiple sclerosis. | Q39408674 | ||
| RelB nuclear translocation mediated by C-terminal activator regions of Epstein-Barr virus-encoded latent membrane protein 1 and its effect on antigen-presenting function in B cells | Q39682474 | ||
| In vivo characterization of transplanted human embryonic stem cell-derived pancreatic endocrine islet cells | Q39911145 | ||
| Directed differentiation of human embryonic stem cells into the pancreatic endocrine lineage. | Q40085672 | ||
| Response to self antigen imprints regulatory memory in tissues | Q40573313 | ||
| Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis. | Q41180997 | ||
| Human induced pluripotent stem cells differentiate into insulin-producing cells able to engraft in vivo | Q41316869 | ||
| iPSC-derived neural precursors exert a neuroprotective role in immune-mediated demyelination via the secretion of LIF. | Q45824204 | ||
| Generation of systemic lupus erythematosus-specific induced pluripotent stem cells from urine | Q45885275 | ||
| Directed differentiation of human pluripotent stem cells along the pancreatic endocrine lineage | Q46082585 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1193-1206 | |
| P577 | publication date | 2015-05-28 | |
| P1433 | published in | Journal of Clinical Medicine | Q27724774 |
| P1476 | title | The Possible Future Roles for iPSC-Derived Therapy for Autoimmune Diseases | |
| P478 | volume | 4 |
| Q42046446 | Cytokine-free directed differentiation of human pluripotent stem cells efficiently produces hemogenic endothelium with lymphoid potential |
| Q64236762 | Global Proteomic and Methylome Analysis in Human Induced Pluripotent Stem Cells Reveals Overexpression of a Human TLR3 Affecting Proper Innate Immune Response Signaling |
| Q39279957 | Neural Stem Cell-Based Regenerative Approaches for the Treatment of Multiple Sclerosis |
| Q94398219 | Stem cell therapy for multiple sclerosis |
Search more.